Peter Virsik
Directeur des opérations chez ESSA PHARMA INC.
Fortune : 68 826 $ au 30/04/2024
Postes actifs de Peter Virsik
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ESSA PHARMA INC. | Directeur des opérations | 01/08/2016 | - |
Historique de carrière de Peter Virsik
Anciens postes connus de Peter Virsik
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| XENOPORT, INC. | Corporate Officer/Principal | 01/01/2005 | 01/01/2015 |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 01/01/2000 | 01/01/2005 |
Formation de Peter Virsik
| Kellogg School of Management | Masters Business Admin |
| University of Michigan | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Canada | 2 |
Opérationnelle
| Corporate Officer/Principal | 2 |
| Masters Business Admin | 1 |
| Graduate Degree | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ESSA PHARMA INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
XenoPort, Inc.
 XenoPort, Inc. Pharmaceuticals: MajorHealth Technology XenoPort, Inc. operated as a biopharmaceutical company. Its products included horizant and regnite. The company was founded by Ronald W. Barrett, William J. Dower and Mark A. Gallop on December 17, 1999 and was headquartered in Atlanta, GA. | Health Technology |
- Bourse
- Insiders
- Peter Virsik
- Expérience
